NCI

COVID-19 could slow progress in reducing cancer death, NCI head warns
Biopharma Dive
Mon, 06/1/20 - 10:36 am
cancer
cancer deaths
COVID-19
NCI
pandemic
SBIR Awards $2.3 Million Grant to Agilvax to Advance Immunotherapy for Triple Negative Breast Cancer
CP Wire
Tue, 08/7/18 - 11:33 am
SBIR
Agilvax
NCI
AX09
Ortho Biotech, NCI ink development deal
Fierce Biotech
Fri, 06/5/09 - 09:47 am
Ortho Biotech
NCI
partnerships